Table 2 Summary of the prevalence estimation for thalassemia.

From: The prevalence of thalassemia in mainland China: evidence from epidemiological surveys

Types

Items

N

n

Cases

Prevalence (%)

Gene frequency (%)

95%CI

I2 (%)

α-thalassemia

total

12

84598

7696

7.88

5.54~10.23

99.7

subtypes

--SEA

9

104578

2958

2.54

1.57~3.51

99

3.7

9

104578

1598

1.59

0.93~2.24

98.8

4.2

9

104578

554

0.54

0.31~0.78

96.7

αCSα

8

102464

249

0.24

0.16~0.32

97.1

αWSα

5

94308

355

0.26

0.17~0.36

98.9

αQSα

9

104578

92

0.06

0.02~0.10

88.9

diagnostic method

gene analysis

11

79198

6859

7.42

5.12~9.72

99.6

no gene analysis

1

5400

837

15.50

14.53~16.47

99.7

year

1991~2000

3

7434

1055

12.38

8.73~16.03

93.9

2001~2010

6

36752

2716

10.36

6.83~13.89

99.4

2011~

2

27591

3586

9.28

1.33~17.23

99.2

β-thalassemia

total

13

439874

6001

2.21

1.93~2.48

99.6

subtypes

CD41/42

7

112712

931

0.93

0.54~1.32

98.4

IVS-2-654

7

112712

448

0.25

0.11~0.40

94.8

CD71/72

6

109260

83

0.07

0.03~0.12

92

CD26

7

112712

68

0.07

0.03~0.10

81.9

-28

6

109260

262

0.25

0.11~0.38

96.1

CD17

7

112712

387

0.48

0.30~0.65

97.4

diagnostic method

gene analysis

10

72598

3353

4.39

2.91~5.87

99

no gene analysis

3

367276

2648

0.92

0.69~1.16

99.5

year

1981~1990

1

2473

13

0.53

0.24~0.82

1991~2000

3

12277

685

6.06

4.53~7.59

90

2001~2010

5

34469

1657

4.92

1.90~7.95

99.4

2011~

3

29317

1246

2.64

0.35~4.93

98.3

α+β-thalassemia

total

6

44734

220

0.48

0.18~0.79

96

year

1991~2000

2

4812

27

0.72

−0.17~1.61

87.8

2001~2010

2

12331

22

0.59

−0.50~1.67

91.2

2011~

2

27591

171

0.37

−0.17~0.91

96.4